Currently out of the existing stock ratings of Keith Hinton, 7 are a BUY (100%).

Keith Hinton

Work Performance Price Targets & Ratings Chart

Analyst Keith Hinton, currently employed at FREEDOM CAPITAL MARKETS, carries an average stock price target met ratio of 27.78% that have a potential upside of 20.68% achieved within 18 days.

Keith Hinton’s has documented 14 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INSP, Inspire Medical Systems.

Wall Street Analyst Keith Hinton

Analyst best performing recommendations are on VCYT (VERACYTE).
The best stock recommendation documented was for VCYT (VERACYTE) at 10/16/2025. The price target of $45 was fulfilled within 20 days with a profit of $9.19 (25.66%) receiving and performance score of 12.83.

Average potential price target upside

VCYT Veracyte ENOV Enovis Corp INSP Inspire Medical Systems

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Oct-2025

$66

$20.19 (44.07%)

19 days ago
(15-Sep-2026)

1/2 (50%)

$25.86 (64.42%)

20

Buy Since 15-Nov-2024

$65

$19.57 (43.08%)

$50

25 days ago
(09-Sep-2026)

1/2 (50%)

$21.14 (48.20%)

578

Buy Since 15-Jul-2026

$54

$8.57 (18.86%)

$66

2 months ago
(04-Aug-2026)

0/2 (0%)

$7.59 (16.35%)

Sell Since 09-Sep-2020

$44

$-1.81 (-3.95%)

$47

2 months ago
(04-Aug-2026)

18/18 (100%)

$-2.41 (-5.19%)

75

Buy Since 06-Jan-2022

$55

$9.19 (20.06%)

$45

2 months ago
(04-Aug-2026)

2/3 (66.67%)

$8.59 (18.51%)

924

Show more analysts

Please expand the browser size to see the chart

Which stock is Keith Hinton most bullish on?

Potential upside of $27.03 has been obtained for INSP (INSPIRE MEDICAL SYSTEMS)

Which stock is Keith Hinton most reserved on?

Potential downside of $18.23 has been obtained for ENOV (ENOVIS CORP)

What Year was the first public recommendation made by Keith Hinton?

On 2025
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?